USPH (U S Physical Therapy Inc /Nv) — AI Stock Analysis & Recommendation

Research of August 26, 2026 · Healthcare / Services-Health Services

TradeFlare's AI research teams rate USPH a HOLD. The latest price is $85.44.

The research plan

• Entry: $77.32
• Time horizon: weeks

The stock is in a neutral market regime and exhibits conflicting signals across technical, fundamental, and sentiment teams, preventing a clear directional bias.

Why

USPH presents a mixed picture with a scanner trigger indicating a potential oversold bounce, but this is overshadowed by a neutral market regime and a lack of strong conviction from any single directional team. The high risk score and conflicting signals across technicals and fundamentals necessitate a HOLD until a clearer directional bias emerges.

What could push USPH higher

• Potential for a mean-reversion bounce from oversold RSI levels.
• Strategic growth initiatives and acquisitions could drive future performance.
• Positive analyst sentiment and institutional accumulation suggest underlying support.

Key risks for USPH

• Significant year-over-year earnings decline and negative net income raise fundamental concerns.
• High realized volatility and a deep historical drawdown indicate substantial price risk.
• Conflicting technical signals, with bearish momentum indicators despite slightly bullish moving averages.

What each AI research team found

Fundamental team: Neutral · valuation: fair

USPH presents a mixed fundamental picture with positive revenue growth and strong analyst sentiment offset by a significant earnings decline and higher leverage. The fair valuation, coupled with the potential for earnings recovery and upside indicated by analyst targets, warrants a neutral stance, with entry around current levels and a target aligned with consensus.

• Significant year-over-year earnings decline (-56.5%) is a major concern, despite positive revenue growth (8.5%).
• Forward P/E of 22.9x suggests expected earnings recovery, but PEG ratio of 2.84 indicates current valuation is expensive relative to expected growth.
• Debt-to-equity ratio of 50.3% is manageable, but the proxy from SEC liabilities over equity (1.07x) suggests higher leverage.

Technical team: Neutral

The stock is in a neutral consolidation phase with conflicting signals from trend and momentum indicators. While near support, the lack of strong volume and bearish momentum suggests caution, making a neutral verdict appropriate until a clear directional breakout occurs.

• The price is consolidating between key support ($77.02) and resistance ($80.16), with the MA20 above the MA50, suggesting a neutral outlook with a slight short-term bullish bias.
• Volume has been below average, indicating a lack of strong conviction, and a significant spike on 2026-01-15 suggests potential distribution.
• Momentum indicators (MACD, Stochastic) are showing bearish signals, while RSI is neutral, suggesting potential downside risk.

Sentiment team: Neutral

USPH presents a neutral overall sentiment, balancing positive analyst views and institutional interest with mixed news and social media sentiment stemming from recent earnings pressures. While growth initiatives and analyst consensus are supportive, near-term cost concerns and an earnings miss temper immediate bullish conviction.

• U.S. Physical Therapy (USPH) news sentiment is neutral, driven by a mix of strategic growth initiatives like acquisitions and AI implementation, alongside concerns regarding employee healthcare costs and a recent earnings miss, with upcoming earnings in...
• USPH exhibits a neutral sentiment driven by mixed Q2 earnings results, with record visit volumes offset by cost pressures, while analysts maintain a cautiously optimistic outlook with a moderate buy rating and upside potential. (Score: 0.021)
• USPH exhibits a positive sentiment driven by strong analyst consensus, insider buying, and institutional accumulation, despite some near-term cost pressures and potential economic headwinds. (Consensus: POSITIVE)

Risk team: High

USPH presents a high-risk profile due to its significant historical drawdown, elevated volatility, and persistent net losses. While the oversold RSI suggests a potential bounce, the underlying financial and market risks necessitate a cautious approach. Position sizing should be small, with a tight stop-loss to manage downside.

• Deep Drawdown (1Y): The stock has experienced a significant price decline over the past year (-52.07%), indicating substantial past volatility and potential for further downside.
• High Realized Volatility: Elevated annualized volatility (20d: 30.04%, 60d: 34.92%) suggests significant price fluctuations and increased risk.
• Negative Net Income (TTM): The company has incurred a net loss over the trailing twelve months (-$8.054 million), raising concerns about profitability and financial sustainability.

USPH at a glance

Market value	$1.2B
Price / earnings	464.0
Revenue growth (year over year)	11.3%
Profit margin	6.1%
Debt / equity	0.48

Every AI call on USPH since June 12, 2026, and what happened next (3 calls) →

Research of August 26, 2026 · AI-generated analysis for educational purposes, can be wrong, not financial advice.